EBV latent membrane protein 1 activates Akt, NFκB, and Stat3 in B cell lymphomas
2007

LMP1 Activates Key Signaling Pathways in B Cell Lymphomas

Sample size: 11 publication 10 minutes Evidence: high

Author Information

Author(s): Shair Kathy H. Y, Bendt Katherine M, Edwards Rachel H, Bedford Elisabeth C, Nielsen Judith N, Raab-Traub Nancy

Primary Institution: Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

Hypothesis

LMP1 promotes lymphoma development in B-1a lymphocytes through activation of specific signaling pathways.

Conclusion

LMP1 enhances the growth and survival of B cell lymphomas by activating the Akt, NFκB, and Stat3 pathways.

Supporting Evidence

  • LMP1 expression correlates with increased lymphoma incidence in transgenic mice.
  • LMP1 transgenic lymphocytes show enhanced viability and proliferation in vitro.
  • Inhibition of Akt, NFκB, and Stat3 pathways blocks growth of lymphoma cells.
  • LMP1 promotes malignancy specifically in B-1a lymphocytes.

Takeaway

This study shows that a protein from the Epstein-Barr virus helps certain immune cells grow into cancer by turning on important growth signals.

Methodology

Transgenic mice expressing LMP1 were used to study lymphoma development and signaling pathways in B-1a lymphocytes.

Limitations

The study primarily focuses on transgenic mice, which may not fully represent human disease.

Participant Demographics

Transgenic mice, specifically LMP1 transgenic mice and wild-type controls.

Digital Object Identifier (DOI)

10.1371/journal.ppat.0030166

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication